Dr. Brain Raises Additional Series-A Funding of ￥10 Million

 (VCBeat) Mar. 15, 2021 -- Dr. Brain announced that announced it has extended that investment round by an additional ￥10 million, with China Venture Capital as the sole investor. According to this startup, the fresh round of funding will be used towards the R&D of self-developed technologies, the further combination of AI-powered diagnosis and treatment products focusing on brain diseases, the two-way implementation of core products in hospitals and physical examinations, and business expansion of primary medical institutions through the "AI + remoted brain imaging platform". In the past four years, Dr. Brain has received investments from Dalton Capital, Haier Capital, and Beilu Pharmaceutical.

Since it was founded in 2017, Dr. Brain adheres to the vision of "to do the top international AI-based brain imaging company", engaged in the original technology of brain science and neuroimaging and focused on precise diagnosis and treatment solutions of neurodegenerative diseases represented by Alzheimer and cerebrovascular diseases represented by stroke. 

Dr. Brain's first AI diagnostic platform for CNS diseases, "Dr. Brain", is based on the company's own database of all-age Chinese whole-brain imaging samples, and employs cloud computing and deep learning algorithms to accurately assess changes in the brain structure and to perform diagnosis and screening. So far, the Dr. Brain platform has obtained more than 20 domestic and international patents for inventions.

Dr. Brain has established long-term strategic partnerships with over 100 Grade III Level A hospitals in China, including Peking Union Medical College Hospital and Xiangya Hospital, providing them with one-stop, AI-assisted diagnostic tools, which significantly improve the accuracy and efficiency of clinical diagnosis. 

In the field of disease prevention and control, Dr. Brain joins hands with the world's top research institutions. In the domain of insurance, the company and Ping An Insurance jointly launched China's first preventive health care insurance plan for Alzheimer's disease, pioneering the application of AI in medicine. In the area of physical examination, Dr. Brain has, in strategic cooperation with the two largest physical exam groups in China.

Established in 2000, China Venture Capital is a professional investor with venture capital and fund management as its main businesses. It is one of the important pioneers in the local venture capital market in China.

The company currently manages dozens of RMB funds. The company's investment covers angel rounds, venture capital, equity funds, industrial merger and acquisition, etc. The company's key investment areas include energy conservation and environmental protection, new materials, new energy, high-end manufacturing, rail transit, military aerospace, medicine and healthcare, Internet, etc.

Haier Capital, founded in 2010, is an investment platform of Haier Financial Holdings. Haier Capital focuses on investment opportunities in medicine and healthcare, smart technology and innovative consumption. By 2020, its AUM has exceeded 19 billion yuan.